Evaristo Sanches
Overview
Explore the profile of Evaristo Sanches including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
44
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thaler J, Greil R, Gaenzer J, Eisterer W, Tschmelitsch J, Samonigg H, et al.
Ann Oncol
. 2015 Mar;
26(4):822-825.
PMID: 25814651
No abstract available.
2.
Pinto P, Rocha P, Veiga I, Guedes J, Pinheiro M, Peixoto A, et al.
Cancer Genet
. 2011 Oct;
204(8):439-46.
PMID: 21962894
Cetuximab and panitumumab are two monoclonal antibodies targeting the epidermal growth factor receptor that have been approved for treatment of metastatic colorectal cancer. Recent clinical trials found an association between...
3.
Popov I, Carrato A, Sobrero A, Vincent M, Kerr D, Labianca R, et al.
Eur J Cancer
. 2008 Aug;
44(15):2204-11.
PMID: 18707870
Objectives: PETACC-1 assessed if raltitrexed is non-inferior to 5-fluorouracil and leucovorin for relapse-free survival (RFS) and overall survival (OS) in adjuvant stage III colon cancer. Methods: Non-inferiority required both HR...
4.
Salgueiro N, Veiga I, Fragoso M, Sousa O, Costa N, Pellon M, et al.
Genet Med
. 2004 Mar;
6(2):102-7.
PMID: 15017333
Purpose: Dihydropyrimidine dehydrogenase is a critical enzyme in the catabolism of 5-Fluorouracil, a drug frequently used in cancer therapy. Patients with deficient dihydropyrimidine dehydrogenase activity are at risk of developing...